Cargando…

Assessment of the Tumor Redox Status in Head and Neck Cancer by (62)Cu-ATSM PET

PURPOSE: Tumor redox is an important factor for cancer progression, resistance to treatments, and a poor prognosis. The aim of the present study was to define tumor redox (over-reduction) using (62)Cu-diacetyl-bis(N(4)-methylthiosemicarbazone) ((62)Cu-ATSM) PET and compare its prognostic potential i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsujikawa, Tetsuya, Asahi, Satoko, Oh, Myungmi, Sato, Yoshitaka, Narita, Norihiko, Makino, Akira, Mori, Tetsuya, Kiyono, Yasushi, Tsuchida, Tatsuro, Kimura, Hirohiko, Fujieda, Shigeharu, Okazawa, Hidehiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4871355/ https://www.ncbi.nlm.nih.gov/pubmed/27187778 http://dx.doi.org/10.1371/journal.pone.0155635

Ejemplares similares

Cerebral Oxidative Stress in Early Alzheimer’s Disease Evaluated by (64)Cu-ATSM PET/MRI: A Preliminary Study
por: Okazawa, Hidehiko, et al.
Publicado: (2022)

Feasibility of Renal Blood Flow Measurement Using (64)Cu-ATSM PET/MRI: A Quantitative PET and MRI Study
por: Nishikawa, Yudai, et al.
Publicado: (2023)

Selected PET radiomic features remain the same
por: Tsujikawa, Tetsuya, et al.
Publicado: (2018)

Assessing the ADC of Bone-marrow on Whole-body MR Imagesin Relation to the Fat-suppression Method and Fat Content
por: Tsujikawa, Tetsuya, et al.
Publicado: (2021)

Noninvasive Measurement of [(11)C]PiB Distribution Volume Using Integrated PET/MRI
por: Okazawa, Hidehiko, et al.
Publicado: (2020)

No significant difference found in PET/MRI CBF values reconstructed with CT-atlas-based and ZTE MR attenuation correction
por: Okazawa, Hidehiko, et al.
Publicado: (2019)

Pixel-by-pixel precise delay correction for measurement of cerebral hemodynamic parameters in H(2)(15)O PET study
por: Islam, Muhammad M., et al.
Publicado: (2017)

Quantitative Assessment of Bone Marrow Activity Using (18)F-FLT PET in Aplastic Anemia and Myelodysplastic Syndromes
por: Tasaki, Toshiki, et al.
Publicado: (2022)

(18)F-FLT PET/MRI for bone marrow failure syndrome-initial experience
por: Tsujikawa, Tetsuya, et al.
Publicado: (2019)

Hematopoiesis in the spleen after engraftment in unrelated cord blood transplantation evaluated by (18)F-FLT PET imaging
por: Araie, Hiroaki, et al.
Publicado: (2023)

Count-based method for specific binding ratio calculation in [I-123]FP-CIT SPECT analysis
por: Rahman, Mahmudur G. M., et al.
Publicado: (2018)

Different Prognostic Implications of (18)F-FDG PET Between Histological Subtypes in Patients With Cervical Cancer
por: Rahman, Tasmiah, et al.
Publicado: (2016)

Evaluation of (R)-[(11)C]PK11195 PET/MRI for Spinal Cord-Related Neuropathic Pain in Patients with Cervical Spinal Disorders
por: Kitade, Makoto, et al.
Publicado: (2022)

Multimodal analysis using [(11)C]PiB-PET/MRI for functional evaluation of patients with Alzheimer’s disease
por: Okazawa, Hidehiko, et al.
Publicado: (2020)

Utilization of Antibody Allows Rapid Clearance of Nanoparticle Probes from Blood without the Need of Probe Modifications
por: Makino, Akira, et al.
Publicado: (2021)

[(18)F]FES PET Resolves the Diagnostic Dilemma of COVID-19-Vaccine-Associated Hypermetabolic Lymphadenopathy in ER-Positive Breast Cancer
por: Nogami, Munenobu, et al.
Publicado: (2023)

Metabolic tumor burden predicts prognosis of ovarian cancer patients who receive platinum‐based adjuvant chemotherapy
por: Yamamoto, Makoto, et al.
Publicado: (2016)

(18)F-FDG/(18)F-FES standardized uptake value ratio determined using PET predicts prognosis in uterine sarcoma
por: Yamamoto, Makoto, et al.
Publicado: (2017)

Cu(II)(atsm) Attenuates Neuroinflammation
por: Choo, Xin Yi, et al.
Publicado: (2018)

Predictive value of 3′-deoxy-3′-(18)F-fluorothymidine PET in the early response to anti-programmed death-1 therapy in patients with advanced non-small cell lung cancer
por: Sato, Masayuki, et al.
Publicado: (2021)

ET-7 EVALUATION OF HYPOXIA-TARGETING RADIOPHARMACEUTICAL(64)CU-ATSM FOR PET MONITORING WITH LOCAL THERAPY IN HIGH-GRADE GLIOMA MODEL
por: Yoshii, Yukie, et al.
Publicado: (2022)

COVID-19 pneumonia detected by [(18)F]FDG PET/MRI: a case with negative antigen test and chest X-ray results
por: Tsujikawa, Tetsuya, et al.
Publicado: (2022)

Arterial Transit Time Mapping Obtained by Pulsed Continuous 3D ASL Imaging with Multiple Post-Label Delay Acquisitions: Comparative Study with PET-CBF in Patients with Chronic Occlusive Cerebrovascular Disease
por: Tsujikawa, Tetsuya, et al.
Publicado: (2016)

Predictive value of integrated (18)F-FDG PET/MRI in the early response to nivolumab in patients with previously treated non-small cell lung cancer
por: Umeda, Yukihiro, et al.
Publicado: (2020)

Assessment of Arterial Transit Time and Cerebrovascular Reactivity in Moyamoya Disease by Simultaneous PET/MRI
por: Takata, Kenji, et al.
Publicado: (2023)

(64)Cu-ATSM and (18)FDG PET uptake and (64)Cu-ATSM autoradiography in spontaneous canine tumors: comparison with pimonidazole hypoxia immunohistochemistry
por: Hansen, Anders E, et al.
Publicado: (2012)

Diagnostic value of [(18)F]FDG PET/MRI for staging in patients with ovarian cancer
por: Tsuyoshi, Hideaki, et al.
Publicado: (2020)

Diagnostic value of (18)F-FDG PET/MRI for staging in patients with endometrial cancer
por: Tsuyoshi, Hideaki, et al.
Publicado: (2020)

Diagnostic Value of (18)F-FDG PET/MRI for Revised 2018 FIGO Staging in Patients with Cervical Cancer
por: Tsuyoshi, Hideaki, et al.
Publicado: (2021)

A Novel Automatic Approach for Calculation of the Specific Binding Ratio in [I-123]FP-CIT SPECT
por: Rahman, Mahmudur G. M., et al.
Publicado: (2020)

Multiple Administrations of (64)Cu-ATSM as a Novel Therapeutic Option for Glioblastoma: a Translational Study Using Mice with Xenografts
por: Yoshii, Yukie, et al.
Publicado: (2017)

CuATSM efficacy is independently replicated in a SOD1 mouse model of ALS while unmetallated ATSM therapy fails to reveal benefits
por: Vieira, Fernando G., et al.
Publicado: (2017)

Specific Binding Ratio Estimation of [(123)I]-FP-CIT SPECT Using Frontal Projection Image and Machine Learning
por: Kita, Akinobu, et al.
Publicado: (2023)

Prognostic value of (18)F-FDG PET in uterine cervical cancer patients with stage IIICr allocated by imaging
por: Isaji, Yuzu, et al.
Publicado: (2023)

Cellular Uptake of the ATSM−Cu(II) Complex under Hypoxic Conditions
por: Walke, Gulshan R., et al.
Publicado: (2021)

Integrated [(18)F]FDG PET/MRI demonstrates the iron-related bone-marrow physiology
por: Tsujikawa, Tetsuya, et al.
Publicado: (2020)

Does the ATSM-Cu(II) Biomarker Integrate into the Human Cellular Copper Cycle?
por: Walke, Gulshan R., et al.
Publicado: (2019)

Dose painting based on tumor uptake of Cu-ATSM and FDG: a comparative study
por: Clausen, Malene Martini, et al.
Publicado: (2014)

Pharmacokinetic Analysis of (64)Cu-ATSM Dynamic PET in Human Xenograft Tumors in Mice
por: Li, Fan, et al.
Publicado: (2015)

Focus on the Controversial Aspects of (64)Cu-ATSM in Tumoral Hypoxia Mapping by PET Imaging
por: Colombié, Mathilde, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_h0lnd6b5oq98pedhhu3nuilm3g